ANGELA BALL: Open Payments
NPI 1093479370 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 14 payments from 13 companies in 2025. Trend: 2023 $275 · 2024 $306 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $46 |
| Viatris Specialty LLC | 1 | $45 |
| Genentech USA, Inc. | 1 | $33 |
| Amgen Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: Wegovy, YUPELRI, Xolair, REPATHA, REXULTI, VERQUVO, Auvelity, Kerendia.
Industry payments across IN — which companies pay providers there.
